Tower Research Capital (TRC)’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100
| Closed | -$3.3K | – | 5705 |
|
|
2024
Q4 | $3.3K | Hold |
100
| – | – | ﹤0.01% | 4672 |
|
|
2024
Q3 | $3.73K | Hold |
100
| – | – | ﹤0.01% | 4780 |
|
|
2024
Q2 | $3.36K | Hold |
100
| – | – | ﹤0.01% | 4898 |
|
|
2024
Q1 | $3.58K | Hold |
100
| – | – | ﹤0.01% | 4835 |
|
|
2023
Q4 | $3.29K | Hold |
100
| – | – | ﹤0.01% | 5095 |
|
|
2023
Q3 | $2.72K | Hold |
100
| – | – | ﹤0.01% | 5109 |
|
|
2023
Q2 | $3.16K | Hold |
100
| – | – | ﹤0.01% | 5076 |
|
|
2023
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 5235 |
|
|
2022
Q4 | $3K | Sell |
100
-22,456
| -100% | -$674K | ﹤0.01% | 5225 |
|
|
2022
Q3 | $680K | Sell |
22,556
-13,198
| -37% | -$398K | 0.01% | 909 |
|
|
2022
Q2 | $990K | Buy |
35,754
+4,438
| +14% | +$123K | 0.02% | 691 |
|
|
2022
Q1 | $1.05M | Buy |
31,316
+15,844
| +102% | +$533K | 0.01% | 770 |
|
|
2021
Q4 | $653K | Sell |
15,472
-3,013
| -16% | -$127K | 0.01% | 936 |
|
|
2021
Q3 | $842K | Sell |
18,485
-33,470
| -64% | -$1.52M | 0.02% | 642 |
|
|
2021
Q2 | $2.54M | Buy |
51,955
+39,956
| +333% | +$1.95M | 0.07% | 239 |
|
|
2021
Q1 | $603K | Buy |
11,999
+991
| +9% | +$49.8K | 0.01% | 1078 |
|
|
2020
Q4 | $564K | Sell |
11,008
-39,315
| -78% | -$2.01M | 0.02% | 898 |
|
|
2020
Q3 | $2.07M | Buy |
50,323
+41,409
| +465% | +$1.7M | 0.02% | 369 |
|
|
2020
Q2 | $373K | Sell |
8,914
-783
| -8% | -$32.8K | 0.02% | 1260 |
|
|
2020
Q1 | $307K | Buy |
9,697
+1,348
| +16% | +$42.7K | 0.02% | 597 |
|
|
2019
Q4 | $353K | Sell |
8,349
-15,895
| -66% | -$672K | 0.03% | 387 |
|
|
2019
Q3 | $765K | Buy |
24,244
+1,624
| +7% | +$51.2K | 0.05% | 381 |
|
|
2019
Q2 | $817K | Buy |
22,620
+84
| +0.4% | +$3.03K | 0.06% | 324 |
|
|
2019
Q1 | $815K | Sell |
22,536
-3,217
| -12% | -$116K | 0.05% | 358 |
|
|
2018
Q4 | $725K | Buy |
25,753
+7,209
| +39% | +$203K | 0.05% | 331 |
|
|
2018
Q3 | $730K | Buy |
+18,544
| New | +$730K | 0.05% | 318 |
|